Targeting Potential of Innate Lymphoid Cells in Melanoma and Other Cancers.

Seo, Hobin; Verma, Amisha; Kinzel, Megan; Huang, Qiutong; Mahoney, Douglas J; Jacquelot, Nicolas

Seo, Hobin; Verma, Amisha; Kinzel, Megan; Huang, Qiutong; Mahoney, Douglas J; Jacquelot, Nicolas.

Afiliación

Seo H; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Verma A; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Kinzel M; Arnie Charbonneau Cancer Research Institute, Calgary, AB T2N 4N1, Canada.
Huang Q; Department of Biological Sciences, University of Calgary, Calgary, AB T2N 4N1, Canada.
Mahoney DJ; Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Jacquelot N; Department of Microbiology, Immunology and Infectious Diseases, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.

Pharmaceutics ; 15(7)2023 Jul 21.

Article en En | MEDLINE | ID: mdl-37514187

Palabras clave

NK cells; PD-1; cancer; cytokines; immune cells; immune checkpoints; immunotherapy; innate immunity; innate lymphoid cells; melanoma

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmaceutics Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google